Xenon Pharmaceuticals (XENE) FCF Margin Growth (5y) (2019 - 2025)

Xenon Pharmaceuticals (XENE) FCF Margin Growth (5y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Xenon Pharmaceuticals 6.03 Bn 6.03 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -62,884.00
Sep 30, 2022 -2.01 Mn
Jun 30, 2022 4.28 Mn
Mar 31, 2022 4.10 Mn
Dec 31, 2021 68,153.00
Sep 30, 2021 91,907.00
Jun 30, 2021 71,350.00
Mar 31, 2021 35,200.00
Dec 31, 2020 -10,369.00
Sep 30, 2020 -6,345.00
Jun 30, 2020 -2,084.00
Mar 31, 2020 -5,333.00
Dec 31, 2019 65,291.00
Sep 30, 2019 -24,863.00